IP Library Granted Patent US 11,530,392
Granted Patent B2
US 11,530,392 · App. 16/770,923 · Granted Dec 20, 2022

DPO4 polymerase variants with improved accuracy

Inventors: Mark Kokoris (Bothell, WA); Marc Prindle (Seattle, WA); Gregory Scott Thiessen (Seattle, WA); Alexander Isaac Lehmann (Seattle, WA); Drew Goodman (Seattle, WA); Aaron Jacobs (Seattle, WA); John Chase (Seattle, WA)
Assignee: Stratos Genomics, Inc.
C12N9/1252C12Y207/07007
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,530,392
App. No.
16/770,923
Granted
Dec 20, 2022
Kind
B2
Abstract

Recombinant DPO4-type DNA polymerase variants with amino acid substitutions that confer modified properties upon the polymerase for improved single molecule sequencing applications are provided. Such properties may include enhanced binding and accurate incorporation of bulky nucleotide analog substrates into daughter strands and the like. Also provided are compositions comprising such DPO4 variants and nucleotide analogs, as well as nucleic acids which encode the polymerases with the aforementioned phenotypes.

Claims (6)

1. An isolated recombinant DNA polymerase, which recombinant DNA polymerase comprises an amino acid sequence that is at least 90% identical to amino acids 1-340 of SEQ ID NO:1, which recombinant polymerase comprises a mutation at amino acid positions 63, 76, 78, 79, 82, 83, 86, 254, and 289, wherein the mutation at amino acid position 63 is E63R, the mutation at amino acid position 76 is M76W, the mutation at amino acid position 78 is K78D, the mutation at amino acid position 79 is E79L, the mutation at amino acid position 82 is Q82W, the mutation at amino acid position 86 is S86E, the mutation at amino acid position 254 is N254K or N254D, and the mutation at amino acid position 289 is V289W wherein identification of positions is relative to wildtype DPO4 polymerase (SEQ ID NO:1), and which recombinant DNA polymerase exhibits polymerase activity.

2. The polymerases of claim 1 , further comprising at least one mutation at an amino acid position selected from the group consisting of 42, 56, 152, 153, 155, 156, 184, 187, 188, 189, 190, 248, 290, 291, 292, 293, 294, 295, 296, 297, 299, 300, 301, 317, 321, 324, 325, and 327.

3. The polymerase of claim 2 , wherein the mutations at amino acid positions 42, 56, 152, 153, 155, 156, 184, 187, 188, 189, 190, 248, 290, 291, 292, 293, 294, 295, 296, 297, 299, 300, 301, 317, 321, 324, 325, and 327 are A42V, K56Y, K152L or K152A, I153T or I153V, A155G, D156R, P184L or P184Q, G187P, N188Y, I189W or I189F, T190Y, I248T, T290K, E291S, D292Y, L293W, D294N, I295S, V296Q, S297Y, G299W, R300S, T301W, K317Q, K321Q, E324K, E325K, and E327K.

4. A composition comprising a recombinant DNA polymerase as set forth in claim 1 .

5. The composition of claim 4 , wherein the composition is present in a DNA sequencing system that comprises at least one non-natural nucleotide analog substrate.

6. The polymerase of claim 1 , wherein amino acids 341-352 relative to wildtype DPO4 polymerase (SEQ ID NO: 1) are deleted.

Assignments (3)
CHANGE OF NAME Recorded Nov 1, 2023
From: STRATOS GENOMICS, INC.
To: ROCHE DIAGNOSTICS SEATTLE, INC.
Reel/Frame 065419/0739 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2023
From: ROCHE DIAGNOSTICS SEATTLE, INC.
To: ROCHE SEQUENCING SOLUTIONS, INC.
Reel/Frame 065419/0919 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 16, 2022
From: KOKORIS, MARK; PRINDLE, MARC; THIESSEN, GREGORY SCOTT; LEHMANN, ALEXANDER ISAAC; GOODMAN, DREW; JACOBS, AARON; CHASE, JOHN
To: STRATOS GENOMICS, INC.
Reel/Frame 061793/0573 →
Continuity (3)
Provisional Application 62597109 · Dec 11, 2017
Provisional Application 62656696 · Apr 12, 2018
Related Publication 20210163903A1 · Jun 3, 2021